RETRACTED: ALLERGENIC EXTRACTS STANDARDIZATION: PROSPECTS FOR THE FUTURE
Abstract
This article reviews the methodological basic procedures of the allergenic extracts standardization protocols used for the allergen-specific immunotherapy in the world nowadays. The comparative analysis of the normative documents regulating the basic technological stages of allergenic extracts production was carried out. The data concerning the production and quality control of this biological drugs group was generalized. It is shown that the method of tandem mass spectrometry of high resolution combined with high performance liquid chromatography could be advantageously employed in the study area.
About the Authors
V. V. Smirnov
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Valerij Valerjevich Smirnov, PhD, head of the Department of normative support in the field of medicines, senior lecturer of the chair of pharmaceutical and toxicological chemistry
13 Nikitsky Boulevard, Moscow, 119019
Tel.: 8 (495) 691–13–92
D. O. Bokov
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
student of the 5-th year of the Pharmaceutical faculty
Moscow
References
1. Maslova L.V. Hay fever: disease control methods // Recept. 2013; 3: 118–127.
2. Peredkova E.V. Pollen allergy // Consilium medicum. 2009; 11 (3): 63–66.
3. Pukhlik B.M. The method proved in time // Novosti mediciny i farmacii: vseukr. spec. med.-farmac. izd. 2012; 1/2: 3–4.
4. Ukraine Association of allergists. [Electronic resource]: The history of allergy: http://www.aalu.org.ua/history/75-history
5. Guschin I.S. Allergen-specific immunotherapy (hyposensitization) // Lechaschy vrach. 2001; 3: 10–27.
6. Kurbachyova O.M., Pavlova K.S. Allergen-specific immunotherapy // Doktor.ru. 2010; 3: 16–19.
7. Vorobyova O.V. Comparative and historical analysis of methodological progress in allergology: allergen-specific immunotherapy. PhD diss. abstract. M. 2012. 24 p.
8. Kurbachyova O.M. Clinical, pathogenetic and economic aspects of allergen-specific immunotherapy. Doctoral diss. abstract. M. 2007. 47 p.
9. Vorobyova O.V. Current state of standardization of allergens in allergen-specific immunotherapy // Rossijsky allergologichesky zhurnal. 2011; 4 (1): 76–77.
10. Zheltikova T.M. Allergens for allergen-specific immunotherapy: Achievements and challenges // Consilium medicum (Pediatriya). 2012; 1: 29–31.
11. Fernández-Caldas E., Zakzuk J., Lockey F.R. et al. Allergen Standardization and Characterization. [Электронный ресурс]. Режим доступа: http://www.worldallergy.org/professional/allergic_diseases_center/allergen_standardization/ (дата обращения: 24.07.2013).
12. Khaitov R.M., Ilyina N.I. Allergology and immunology: National guidelines. M.: Geotar-Media. 2009. 649 p.
13. Khaitov R.M., Fedoseeva V.N., Ilyina N.I. et al. Application for a specific allergen immunotherapy allergenpolimer conjugated vaccines (pollen allergotropine new generation) // Terapevticheskij arkhiv. 2002; 10: 37–40.
14. Astafjeva N.G., Gamova I.V., Udovichenko E.N. et al. The place of allergen-specific immunotherapy in the treatment of atopic dermatitis // Consilium medicum. 2013; 3: 55–61.
15. Pukhlik B.M., Kyazimova A.T. The role of specific immunotherapy in the treatment of allergic diseases and the oral method advances // Klinicheskaya immunologiya. Allergologiya. Infektologiya. 2010; 7: 38–43.
16. Van Ree R., Chapman M.D., Ferreira F. et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification // Allergy. 2008; 63: 310–326.
17. European pharmacopoeia. 7-th ed. suppl. 7.0. Strasbourg: European Department for the Quality of Medicines. 2010; 1: 1207 р.
18. Code of Federal Regulations Food and Drug Administration (21 680.1) – «Allergenic Products». Vol. 7. Date: 2011–04–01. P. 133–136.
19. Pronkina O.V. New diagnostic allergen of Canadian goldenrod plants (Solidago canadensis) and its immunobiological properties. PhD diss. abstract. M. 2008. 22 p.
20. Pavlov A.E., Sejlieva N.A., Mukhortykh O.Yu. et al. Preparation and evaluation of the properties of recombinant analog of majeure allergen of birch pollen Bet v 1 // Rossijsky allergologichesky zhurnal. 2012; 3: 7–13.
21. Nikonova M.F., Doneckova A.M., Andreev I.V. et al. Biological effects of drugs of pollen allergens in human lymphocyte culture // Immunologiya. 2012; 2: 86–89.
22. Vidal Handbook. Drugs in Russia. М.: AstraFarmServis. 2013. 1640 p.
23. Mokronosova M.A., Korovkina E.S. Allergen-specific immunotherapy with pollen allergen extract of trees adsorbed on calcium phosphate suspension // Rossijsky allergologichesky zhurnal. 2010; 4: 79–84.
24. Stallergenes S.A. [Электронный ресурс]: Stallergenes group. Режим доступа: http://www.stallergenes.com/en/stallergenes-group/our-products.html (дата обращения: 19.07.2013).
25. American Immunization Registry Association. [Электронный ресурс]: Promoting the development, implementation and interoperability of Immunization Information Systems. Режим доступа: http://www.immregistries.org/about-aira (дата обращения: 21.07.2013).
26. LC/MS Information. [Электронный ресурс]: Technology Reviews. Режим доступа: http://www.lcms.com/lcms_information/refer_books.html (дата обращения: 19.07.2013).
27. Bokov D.O. Developing the approaches to standardization and quality control of allergenic extracts used during allergen-specific immunotherapy (SIT) // Medicinskaya vesna: sbornik materialov Itogovoj Vserossijskoj studencheskoj nauchnoj konferencii s mezhdunarodnym uchastiem (25–26 aprelya 2013 g.). M.: Izd-vo Pervogo MGMU im. I.M. Sechenova. 2013: 225–227.
28. Laskin J., Lifshic Kh. Principles of mass spectrometry in the annex to biomolecules. M.: Tekhnosfera. 2012. 608 p.
29. Rodin I.A., Varlamov V.V. Innovative chromatographymass spectrometers Shimadzu in laboratory practice of the 21-st century // Analitika. Oborudovanie i materialy. 2012; 1: 6–10.
Review
Views: 48
Email this article 